1. Home
  2. ARCT vs UHT Comparison

ARCT vs UHT Comparison

Compare ARCT & UHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARCT
  • UHT
  • Stock Information
  • Founded
  • ARCT 2013
  • UHT 1986
  • Country
  • ARCT United States
  • UHT United States
  • Employees
  • ARCT N/A
  • UHT N/A
  • Industry
  • ARCT Biotechnology: Pharmaceutical Preparations
  • UHT Real Estate Investment Trusts
  • Sector
  • ARCT Health Care
  • UHT Real Estate
  • Exchange
  • ARCT Nasdaq
  • UHT Nasdaq
  • Market Cap
  • ARCT 526.5M
  • UHT 515.7M
  • IPO Year
  • ARCT N/A
  • UHT N/A
  • Fundamental
  • Price
  • ARCT $10.59
  • UHT $36.45
  • Analyst Decision
  • ARCT Buy
  • UHT
  • Analyst Count
  • ARCT 10
  • UHT 0
  • Target Price
  • ARCT $35.25
  • UHT N/A
  • AVG Volume (30 Days)
  • ARCT 2.1M
  • UHT 75.1K
  • Earning Date
  • ARCT 11-07-2025
  • UHT 10-27-2025
  • Dividend Yield
  • ARCT N/A
  • UHT 8.12%
  • EPS Growth
  • ARCT N/A
  • UHT N/A
  • EPS
  • ARCT N/A
  • UHT 1.30
  • Revenue
  • ARCT $122,122,000.00
  • UHT $100,639,000.00
  • Revenue This Year
  • ARCT N/A
  • UHT N/A
  • Revenue Next Year
  • ARCT $34.32
  • UHT $0.81
  • P/E Ratio
  • ARCT N/A
  • UHT $28.06
  • Revenue Growth
  • ARCT N/A
  • UHT 0.74
  • 52 Week Low
  • ARCT $8.04
  • UHT $34.56
  • 52 Week High
  • ARCT $24.17
  • UHT $43.38
  • Technical
  • Relative Strength Index (RSI)
  • ARCT 31.16
  • UHT 39.58
  • Support Level
  • ARCT $9.19
  • UHT $36.04
  • Resistance Level
  • ARCT $12.10
  • UHT $37.16
  • Average True Range (ATR)
  • ARCT 1.78
  • UHT 0.75
  • MACD
  • ARCT -1.35
  • UHT 0.10
  • Stochastic Oscillator
  • ARCT 9.36
  • UHT 55.10

About ARCT Arcturus Therapeutics Holdings Inc.

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.

About UHT Universal Health Realty Income Trust

Universal Health Realty Income Trust is a healthcare REIT. The company is engaged in the business of investing in and leasing healthcare and human service facilities through direct ownership or through joint ventures, which aggregate into a single reportable segment. The company actively manages a portfolio of healthcare and human service facilities. The revenue and net income are generated from the operation of the investment portfolio, located throughout the United States.

Share on Social Networks: